MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 FDA-Blessed Wearables and Apps Changing Healthcare - BlueStar

 Product Name: BlueStarDescription: BlueStar is the first mobile prescription therapy that is cleared by the FDA to help type 2 diabetes patients manage their disease.  

Product Name: BlueStar

Company: WellDoc

Description: BlueStar is the first mobile prescription therapy that is cleared by the FDA to help type 2 diabetes patients manage their disease. 

The solution is prescribed by physicians, activated by pharmacies and treated like a pharmacy benefit. WellDoc's mobile solutions incorporate, coaching, education and information tailored to individual diabetics based on their behavior and personal data to keep their blood glucose levels controlled and manage the disease.

To learn more how mobile prescriptions like Welldoc's BlueStar is changing patient engagement in diabetes, attend MD&M East June 14-15 at the Jacob Javits Convention Center in New York City. 

In 2011, the company proved through a clinical trial that when patients used its diabetes management mobile platform for a 12-month period, they were able to reduce ER visits and hospitalizations by 58%. Further, and more importantly, a clinical trial showed that patients using WellDoc's mobile coaching platform were able to reduce their blood glucose levels more than those who were using traditional methods of disease management.

FDA Clearance: 2010

             
 
TAGS: News
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish